← Open Payments lookup

NAA-FOFOI WHARTON: Open Payments

NPI 1639792088 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,086 in 87 payments from 16 companies in 2025. Trend: 2023 $1,188 · 2024 $2,101 · 2025 $3,086

Food & beverage: $3,002Education: $84
CompanyPaymentsAmount
ViiV Healthcare Company28$1,040
Gilead Sciences, Inc.7$433
ABBVIE INC.12$348
Lilly USA, LLC6$207
AstraZeneca Pharmaceuticals LP4$196
Merck Sharp & Dohme LLC7$143
Braeburn Inc.2$130
EMD Serono, Inc.2$127
Neurocrine BioSciences, Inc.3$95
Hologic Sales and Service, LLC3$81

Products named: DOVATO, CABENUVA, MAVYRET, MOUNJARO, TEZSPIRE, Veklury, BRIXADI, Serostim.

Industry payments across PA — which companies pay providers there.